This illustrates clearly that the targeted chromosomal breakpoints in neuroblastoma and the PAX3-FOXO1 fusion gene in the rhabdomyosarcoma patient remain stable during the course of the disease. The gene discussed is FOXO1; the disease is neuroblastoma.